Beyond the specific protein species considered (i.e., p-tau 217, p-tau 181, and p-tau 231), plasma p-tau markers vary in their capability to predict AD according to the assay method and thresholds used [12,17,18]. The gene discussed is MAPT; the disease is Alzheimer disease.